Atea Pharmaceuticals
AVIR
AVIR
142 hedge funds and large institutions have $477M invested in Atea Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.15% less ownership
Funds ownership: 68.67% → 64.51% (-4.2%)
76% less capital invested
Capital invested by funds: $1.99B → $477M (-$1.52B)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
142
Holding in Top 10
–
Calls
$15.8M
Puts
$14.2M
Top Buyers
| 1 | +$48.1M | |
| 2 | +$14.7M | |
| 3 | +$14M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$13.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$190M | |
| 2 | -$79.2M | |
| 3 | -$58M | |
| 4 |
AIIC
AJU IB Investment Company
Seoul,
South Korea
|
-$57.4M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$29M |